Recommendations for the use of Rituximab in neuromyelitis optica spectrum disorders

J. Ciron (1) , B. Audoin (2, 3, 4) , B. Bourre (5) , David Brassat (6, 1) , R. Marignier (7, 8) , F. Durand-Dubief (9) , D. Laplaud (10) , N. Collongues (11, 12, 13) , E. Maillart (14) , C. Papeix (14) , S. Vukusic (7, 15, 8) , H. Zephir (16, 1)

1 Département Neurologie [CHU Toulouse]
2 AP-HM, CHU Timone, Pole de Neurosciences Cliniques, Department of Neurology, Marseille, France.
3 CRMBM - Centre de résonance magnétique biologique et médicale
4 CEMEREM - Centre d'Exploration Métabolique par Résonance Magnétique [Hôpital de la Timone - AP-HM]
5 Department of neurology, university hospital of Rouen
6 CPTP - Centre de Physiopathologie Toulouse Purpan
7 Department of neurology, Sclérose en Plaques, pathologies de la myéline et neuro-inflammation, hôpital neurologique Pierre-Wertheimer, hospices civils de Lyon
8 Inserm U1028 CNRS UMR 5292, FLUID Team, faculté de médecine Laennec, centre de recherche en neurosciences de Lyon
9 Department of neurology, Sclérose en Plaques, pathologies de la myéline et neuro-inflammation, hôpital neurologique Pierre-Wertheimer, hospices civils de Lyon, Lyon
10 Department of neurology, university hospital of Nantes
11 Department of Neurology, University Hospital Strasbourg
12 Clinical Investigation Center, Inserm U1434, university hospital of Strasbourg
13 Biopathology of Myelin, neuroprotection and therapeutic Strategies, Inserm U1119, university hospital of Strasbourg
14 Department of neurology, Pitié-Salpêtrière Hospital, AP-HP, Paris
15 OFSEP - Observatoire Français de la Sclérose En Plaques [Lyon]
16 Département de neurologie [Lille]

Domains: Life Sciences [q-bio]; Immunology; Immunotherapy

J. Ciron, B. Audoin, B. Bourre, David Brassat, R. Marignier, et al.. Recommendations for the use of Rituximab in neuromyelitis optica spectrum disorders. Revue Neurologique, 2018, 174 (4), pp.255-264. ⟨10.1016/j.neurol.2017.11.005⟩. ⟨hal-03538511⟩